Sharon Hertz

12.4k total citations · 2 hit papers
23 papers, 2.2k citations indexed

About

Sharon Hertz is a scholar working on Pharmacology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Sharon Hertz has authored 23 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Psychiatry and Mental health and 5 papers in Cognitive Neuroscience. Recurrent topics in Sharon Hertz's work include Musculoskeletal pain and rehabilitation (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Epilepsy research and treatment (5 papers). Sharon Hertz is often cited by papers focused on Musculoskeletal pain and rehabilitation (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Epilepsy research and treatment (5 papers). Sharon Hertz collaborates with scholars based in United States, Canada and Israel. Sharon Hertz's co-authors include Bob A. Rappaport, Robert H. Dworkin, Dennis C. Turk, Laurie B. Burke, John T. Farrar, Penney Cowan, Sarah Peirce‐Sandner, Gale Harding, Mitchell B. Max and Dennis A. Revicki and has published in prestigious journals such as New England Journal of Medicine, Annals of Neurology and Pain.

In The Last Decade

Sharon Hertz

23 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2)

2009 528 citations Robert H. Dworkin, Dennis C. Turk et al. Pain profile →
Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations

2009 511 citations Robert H. Dworkin, Dennis C. Turk et al. Pain profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sharon Hertz	887	598	418	389	388	23	2.2k
Gabriel Tan	893 1.0×	384 0.6×	320 0.8×	283 0.7×	385 1.0×	21	1.8k
Bob A. Rappaport	986 1.1×	383 0.6×	679 1.6×	456 1.2×	556 1.4×	33	2.8k
Penney Cowan	936 1.1×	377 0.6×	359 0.9×	314 0.8×	365 0.9×	24	1.7k
Beatrice Korwisi	1.1k 1.2×	530 0.9×	542 1.3×	436 1.1×	605 1.6×	28	2.3k
Trong Kim Le	813 0.9×	283 0.5×	290 0.7×	208 0.5×	606 1.6×	43	2.0k
Jacques Devulder	740 0.8×	273 0.5×	531 1.3×	266 0.7×	390 1.0×	64	1.6k
Hilary Wilson	703 0.8×	364 0.6×	259 0.6×	284 0.7×	430 1.1×	66	1.8k
Silviu Brill	750 0.8×	238 0.4×	522 1.2×	211 0.5×	420 1.1×	99	2.0k
Kristin L. Schreiber	599 0.7×	295 0.5×	575 1.4×	354 0.9×	498 1.3×	86	2.3k
Dominique Dion	629 0.7×	295 0.5×	226 0.5×	214 0.6×	413 1.1×	20	1.5k

Countries citing papers authored by Sharon Hertz

Since Specialization

Citations

This map shows the geographic impact of Sharon Hertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Hertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Hertz more than expected).

Fields of papers citing papers by Sharon Hertz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Hertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Hertz. The network helps show where Sharon Hertz may publish in the future.

Co-authorship network of co-authors of Sharon Hertz

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Hertz. A scholar is included among the top collaborators of Sharon Hertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Hertz. Sharon Hertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Langford, Dale J., Jennifer S. Gewandter, Dagmar Amtmann, et al.. (2022). Patient-Reported Chronic Pain Intensity: More Than Meets the Eye. Patient. 15(4). 383–387. 2 indexed citations

Amur, Shashi, et al.. (2020). FDA Experience With Regulation of Naloxone Products to Address the Opioid Crisis and Opportunities for Leveraging Scientific Engagement. Clinical Pharmacology & Therapeutics. 109(3). 569–572. 3 indexed citations

Volkow, Nora D., Janet Woodcock, Wilson M. Compton, et al.. (2018). Medication development in opioid addiction: Meaningful clinical end points. Science Translational Medicine. 10(434). 40 indexed citations

Rappaport, Bob A., Santhanam Suresh, Sharon Hertz, Alex S. Evers, & Beverley A. Orser. (2015). Anesthetic Neurotoxicity — Clinical Implications of Animal Models. New England Journal of Medicine. 372(9). 796–797. 223 indexed citations

Chen, Ling, Silvia N. Calderon, & Sharon Hertz. (2015). Considerations on designs of intranasal studies for abuse-deterrent products. Drug and Alcohol Dependence. 156. e41–e42. 1 indexed citations

Hunsinger, Matthew, Shannon M. Smith, Andrew McKeown, et al.. (2014). Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review. Pain. 155(11). 2253–2262. 22 indexed citations

Smith, Shannon M., Anthony Pereira, Daniel R. Chang, et al.. (2013). Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations. Pain. 154(12). 2769–2774. 24 indexed citations

Smith, Shannon M., Nathaniel P. Katz, Michael McDermott, et al.. (2013). Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 154(7). 997–1008. 46 indexed citations

Gewandter, Jennifer S., Shannon M. Smith, Andrew McKeown, et al.. (2013). Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 155(3). 461–466. 22 indexed citations

10.

Ji, Ping, et al.. (2012). Regulatory Review of Acetaminophen Clinical Pharmacology in Young Pediatric Patients. Journal of Pharmaceutical Sciences. 101(12). 4383–4389. 22 indexed citations

11.

Dworkin, Robert H., Dennis C. Turk, Sarah Peirce‐Sandner, et al.. (2010). Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database. Pain. 150(1). 12–16. 35 indexed citations

12.

Dworkin, Robert H., Dennis C. Turk, Dennis A. Revicki, et al.. (2009). Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 144(1). 35–42. 528 indexed citations breakdown →

13.

Dworkin, Robert H., Dennis C. Turk, Michael McDermott, et al.. (2009). Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain. 146(3). 238–244. 511 indexed citations breakdown →

14.

Turk, Dennis C., Robert H. Dworkin, Dennis A. Revicki, et al.. (2007). Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain. 137(2). 276–285. 374 indexed citations

15.

Durner, Martina, Mehdi Keddache, Livia Tomasini, et al.. (2001). Genome scan of idiopathic generalized epilepsy: Evidence for major susceptibility gene and modifying genes influencing the seizure type. Annals of Neurology. 49(3). 328–335. 107 indexed citations

16.

Durner, Martina, Shlomo Shinnar, Stanley R. Resor, et al.. (2000). No evidence for a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. American Journal of Medical Genetics. 96(1). 49–52. 17 indexed citations

17.

Ribeiro, Márcia, Ernst Niedermeyer, & Sharon Hertz. (1999). SLOW SHARP WAVES: SUGGESTIVE OF SERIOUS CEREBRAL CONDITIONS (METABOLIC-TOXIC-INFECTIOUS). Journal of Clinical Neurophysiology. 16(2). 176–176. 1 indexed citations

18.

Niedermeyer, E., Márcia Ribeiro, & Sharon Hertz. (1999). Mixed-Type Encephalopathies: Preliminary Considerations. Clinical Electroencephalography. 30(1). 12–15. 4 indexed citations

19.

Litt, Brian, et al.. (1998). Nonconvulsive Status Epilepticus in the Critically Ill Elderly. Epilepsia. 39(11). 1194–1202. 186 indexed citations

20.

Gottesman, Malcolm, et al.. (1996). Cardiac Arrest Caused by Trigeminal Neuralgia. Headache The Journal of Head and Face Pain. 36(6). 392–394. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact